Glucotrack Publishes Study Supporting Long-Life Sensor Design for Blood Glucose Monitoring
Glucotrack, Inc. announced the publication of a peer-reviewed study in the IEEE Sensors Journal, demonstrating the long-term stability of its implantable continuous blood glucose monitoring technology. The study outlines the first-year evaluation of glucose oxidase enzyme decay, indicating design feasibility for long-life glucose sensors. This research contributes to Glucotrack’s efforts in developing a continuous blood glucose monitor with a sensor longevity of three years, aiming for clinical and regulatory progress in the near future.
Year-long in-vitro characterization of glucose oxidase stability supports the feasibility of long-life implantable continuous glucose monitors, independent third party review of the longevity and functionality of design in the latter stage of in-human use
Year-long in-vitro characterization of glucose oxidase stability supports the feasibility of long-life implantable continuous glucose monitors, independent third party review of the longevity and functionality of design in the latter stage of in-human use